All the abovementioned results revealed that LAC-positive was in accordance with abnormal levels of hemostatic parameters in patients with NSCLC, and it might be a useful marker indicating coagulation activation in patients with lung cancer. The gene discussed is LCT; the disease is non-small cell lung carcinoma.